The Pediatric Research Equity Act aims to close the gap in pediatric drug testing but faces significant delays in study completion. Rare disease designations exempt nearly half of new drugs from ...
Please provide your email address to receive an email when new articles are posted on . No drugs approved between 2017 and 2020 were subjected to post-approval pediatric testing requirements. After ...
Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "Pediatric Drugs and Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...
Mary Carmack is a researcher in the Pediatric Therapeutics and Regulatory Science Initiative in the Computational Health Informatics Program at Boston Children’s Hospital, in Boston, Massachusetts.
Changes in the regulatory environment in the United States and European Union have the potential to advance the concept of precision medicine to children with cancer. Preclinical testing of targeted ...
May 3, 2012 (Boston, Massachusetts) — The amount of clinical trial research on drugs for children is not keeping up with the burden of disease in children, with developing countries showing the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results